UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Cell cycle-dependent deacetylation of telomeric histone H3 lysine K56 by human SIRT6

Cell cycle (Georgetown, Tex.), 2009-08, Vol.8 (16), p.2664-2666

2009

Volltextzugriff (PDF)

SIRT6 is a histone H3 lysine 9 deacetylase that modulates telomeric chromatin

Nature, 2008-03, Vol.452 (7186), p.492-496

2008

Volltextzugriff (PDF)

SIRT6 stabilizes DNA-dependent Protein Kinase at chromatin for DNA double-strand break repair

Aging (Albany, NY.), 2009-01, Vol.1 (1), p.109-121

2009

Volltextzugriff (PDF)

SIRT6 stabilizes DNA-dependent protein kinase at chromatin for DNA double-strand break repair

Aging (Albany, NY.), 2009-01, Vol.1 (1), p.109-121

2009

Volltextzugriff (PDF)

PD-L1 and tumor-associated macrophages in de novo DLBCL

Blood advances, 2019-02, Vol.3 (4), p.531-540

2019

Volltextzugriff (PDF)

Mutation load and an effector T-cell gene signature may distinguish immunologically distinct and clinically relevant lymphoma subsets

Blood advances, 2017-10, Vol.1 (22), p.1884-1890

2017

Volltextzugriff (PDF)

Comparative molecular cell-of-origin classification of diffuse large B-cell lymphoma based on liquid and tissue biopsies

Translational medicine communications, 2020-03, Vol.5 (1), p.1-13, Article 5

2020

Volltextzugriff (PDF)

Longitudinal Analysis of Circulating Tumor DNA (ctDNA) in Diffuse Large B-Cell Lymphoma (DLBCL) Using KAPA HyperCap Design Share Non-Hodgkin Lymphoma (KAPA HyperCap DS NHL) Next-Generation Sequencing (NGS) Panel

Blood, 2023-11, Vol.142 (Supplement 1), p.6082-6082

2023

Volltextzugriff (PDF)

Patients with worry: presentation of concerns and expectations for response

Patient education and counseling, 2005-05, Vol.57 (2), p.211-216

2005

Volltextzugriff (PDF)

Glofitamab Plus R-CHOP Induces High Response Rates with a Manageable Safety Profile in Patients with Previously Untreated Diffuse Large B-Cell Lymphoma (DLBCL): A 12-Month Analysis from a Phase Ib Study

Blood, 2023-11, Vol.142 (Supplement 1), p.3085-3085

2023

Volltextzugriff (PDF)

Risk Profiling of Patients with Previously Untreated Diffuse Large B-Cell Lymphoma (DLBCL) By Measuring Circulating Tumor DNA (ctDNA): Results from the POLARIX Study

Blood, 2022-11, Vol.140 (Supplement 1), p.1297-1300

2022

Volltextzugriff (PDF)

Mosunetuzumab, a Novel CD20/CD3 Bispecific Antibody, in Combination with CHOP Confers High Response Rates in Patients with Diffuse Large B-Cell Lymphoma

Blood, 2020-11, Vol.136 (Supplement 1), p.37-38

2020

Volltextzugriff (PDF)

High Expression of Programmed Death-Ligand 1 (PD-L1) Correlates with Macrophage Gene Expression and Is Associated with Prolonged Progression-Free Survival (PFS) in Patients (pts) with First-Line (1L) Diffuse Large B-Cell Lymphoma (DLBCL)

Blood, 2017-12, Vol.130, p.195-195

2017

Volltextzugriff (PDF)

Mutation Load and a Functional T Effector Signature May Distinguish Immunologically Distinct and Clinically Relevant Lymphoma Subsets

Blood, 2016-12, Vol.128 (22), p.913-913

2016

Volltextzugriff (PDF)

Physicians' attitudes on advance directives

JAMA : the journal of the American Medical Association, 1989-11, Vol.262 (17), p.2415

1989

Volltextzugriff (PDF)

Responding effectively to patient anger directed at the physician

Family medicine, 2002-05, Vol.34 (5), p.331-336

2002

Volltextzugriff (PDF)

Determining Component Weights in a Communications Assessment Using Judgmental Policy Capturing

Medical education online, 2004-12, Vol.9 (1), p.4352-4352

2004

Volltextzugriff (PDF)

Communication assessment using the common ground instrument: psychometric properties

Family medicine, 2004-03, Vol.36 (3), p.189-198

2004

Volltextzugriff (PDF)

Agenda setting in the patient-physician relationship

JAMA : the journal of the American Medical Association, 1999-09, Vol.282 (10), p.942

1999

Volltextzugriff (PDF)

MEASURING INDUCED EMOTION IN CLINICAL SCENARIOS: A PRELIMINARY FEASIBILITY STUDY

Psychosomatic medicine, 1998, Vol.60 (1), p.132-133

1998

Volltextzugriff (PDF)

Antiviral Effect of Pyran Against Systemic Infection of Mice with Herpes Simplex Virus Type 2

Antimicrobial Agents and Chemotherapy, 1976-07, Vol.10 (1), p.28-33

1976

Volltextzugriff (PDF)

The role of HST1 and RFM1 in the regulation of middle-meiosis specific genes in Saccharomyces cerevisiae

McCord, Ronald Albert

2003

Volltextzugriff (PDF)

Resistance to herpes simplex type 2 virus induced by an immunopotentiator (pyran) in immunosuppressed mice

The Journal of immunology (1950), 1975-07, Vol.115 (1), p.311-313

1975

Volltextzugriff (PDF)

Advance Directives: Do They Provide Direction?-Reply

JAMA : the journal of the American Medical Association, 1990-04, Vol.263 (13), p.1764

Davidson, Kent W.

1990

Volltextzugriff (PDF)

Metabolite profiling stratifies pancreatic ductal adenocarcinomas into subtypes with distinct sensitivities to metabolic inhibitors

Proceedings of the National Academy of Sciences - PNAS, 2015-08, Vol.112 (32), p.E4410-E4417

2015

Volltextzugriff (PDF)

1 – 25 von 47

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(40)
Mit Volltextzugriff
(38)

Publikationsform

Sprache

Englisch
(47)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Cell cycle-dependent deacetylation of telomeric histone H3 lysine K56 by human SIRT6

SIRT6 is a histone H3 lysine 9 deacetylase that modulates telomeric chromatin

SIRT6 stabilizes DNA-dependent Protein Kinase at chromatin for DNA double-strand break repair

SIRT6 stabilizes DNA-dependent protein kinase at chromatin for DNA double-strand break repair

PD-L1 and tumor-associated macrophages in de novo DLBCL

Mutation load and an effector T-cell gene signature may distinguish immunologically distinct and clinically relevant lymphoma subsets

Comparative molecular cell-of-origin classification of diffuse large B-cell lymphoma based on liquid and tissue biopsies

Longitudinal Analysis of Circulating Tumor DNA (ctDNA) in Diffuse Large B-Cell Lymphoma (DLBCL) Using KAPA HyperCap Design Share Non-Hodgkin Lymphoma (KAPA HyperCap DS NHL) Next-Generation Sequencing (NGS) Panel

Patients with worry: presentation of concerns and expectations for response

Glofitamab Plus R-CHOP Induces High Response Rates with a Manageable Safety Profile in Patients with Previously Untreated Diffuse Large B-Cell Lymphoma (DLBCL): A 12-Month Analysis from a Phase Ib Study

Risk Profiling of Patients with Previously Untreated Diffuse Large B-Cell Lymphoma (DLBCL) By Measuring Circulating Tumor DNA (ctDNA): Results from the POLARIX Study

Mosunetuzumab, a Novel CD20/CD3 Bispecific Antibody, in Combination with CHOP Confers High Response Rates in Patients with Diffuse Large B-Cell Lymphoma

High Expression of Programmed Death-Ligand 1 (PD-L1) Correlates with Macrophage Gene Expression and Is Associated with Prolonged Progression-Free Survival (PFS) in Patients (pts) with First-Line (1L) Diffuse Large B-Cell Lymphoma (DLBCL)

Mutation Load and a Functional T Effector Signature May Distinguish Immunologically Distinct and Clinically Relevant Lymphoma Subsets

Physicians' attitudes on advance directives

Responding effectively to patient anger directed at the physician

Determining Component Weights in a Communications Assessment Using Judgmental Policy Capturing

Communication assessment using the common ground instrument: psychometric properties

Agenda setting in the patient-physician relationship

MEASURING INDUCED EMOTION IN CLINICAL SCENARIOS: A PRELIMINARY FEASIBILITY STUDY

Antiviral Effect of Pyran Against Systemic Infection of Mice with Herpes Simplex Virus Type 2

The role of HST1 and RFM1 in the regulation of middle-meiosis specific genes in Saccharomyces cerevisiae

Resistance to herpes simplex type 2 virus induced by an immunopotentiator (pyran) in immunosuppressed mice

Advance Directives: Do They Provide Direction?-Reply

Metabolite profiling stratifies pancreatic ductal adenocarcinomas into subtypes with distinct sensitivities to metabolic inhibitors

Suchergebnisse filtern